Nov 6 (Reuters) - Correvio Pharma Corp CORV.TO :
* CORREVIO REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS
* CORREVIO PHARMA CORP - QTRLY BASIC LOSS PER SHARE OF $0.20
* CORREVIO PHARMA CORP - REVENUE FOR THREE MONTHS ENDED SEPTEMBER 30, 2018 WAS $7.0 MILLION, COMPARED TO REVENUE OF $6.0 MILLION
* CORREVIO PHARMA CORP - AT SEPTEMBER 30, 2018, COMPANY HAD CASH, CASH EQUIVALENTS, AND RESTRICTED CASH OF $18.8 MILLION